Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

AnaptysBio, Inc. , a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.

52W Range

55thpctl

Volume

0.75×avg

Market Cap

1.44BUSD

P/E Ratio

7.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

AnaptysBio, Inc.

ANABNASDAQ·USD·Closed

AnaptysBio, Inc.

ANABNASDAQ·USD·Closed

$48.53

−0.21%

$48.53

−$0.10 (0.21%)

52W Range

55thpctl

Volume

0.75×avg

Mkt Cap

1.44BUSD

P/E

7.2TTM

Div Yield

–ann

ANAB: AnaptysBio, Inc. Stock Analysis | finqOS